Medacta has announced revenue growth of 19% compared with the prior year period in its 2022 half-year financial results, according to a company press release.
The company reported 211.3 million euro in unaudited revenue for the first half of 2022, a 19% increase from the 177.5 million euro in the first half of 2022.
“I am pleased with the revenue performance delivered in the semester, despite the persistent challenging conditions in some geographies,” Francesco Siccardi, CEO of Medacta, said in the release. “We will continue to prioritize our future growth through the execution of our strategy, while adopting initiatives to mitigate impacts of macroeconomic and geopolitical developments.”
According to the release, Medacta has updated its full-year guidance with an expected 414 million euro in full-year revenue, compared with 400 million euro in the original guidance.